Barrington Research Lowers Option Care Health (NASDAQ:OPCH) Price Target to $32.00

Option Care Health (NASDAQ:OPCH) had its target price lowered by Barrington Research from $40.00 to $32.00 in a research report report published on Thursday, Benzinga reports. The firm currently has an outperform rating on the stock. Barrington Research also issued estimates for Option Care Health’s Q4 2024 earnings at $0.32 EPS, Q1 2025 earnings at $0.20 EPS, Q2 2025 earnings at $0.28 EPS, Q3 2025 earnings at $0.30 EPS and Q4 2025 earnings at $0.34 EPS.

A number of other brokerages have also recently weighed in on OPCH. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the company from $38.00 to $26.00 in a report on Thursday. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $31.60.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $24.11 on Thursday. The stock has a market cap of $4.10 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 1.74 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.36. Option Care Health has a 12 month low of $22.84 and a 12 month high of $34.63. The stock’s 50 day moving average price is $30.49 and its 200 day moving average price is $29.91.

Insider Activity

In other news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares in the company, valued at $663,429.51. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently modified their holdings of the company. UMB Bank n.a. increased its position in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its holdings in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the last quarter. Blue Trust Inc. raised its position in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares in the last quarter. Finally, SageView Advisory Group LLC acquired a new stake in Option Care Health in the first quarter valued at approximately $85,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.